PROSTAGLANDINS, ANGIOTENSIN, NUCLEOTIDES IN PREGNANCY
PROSTAGLANDINS, ANGIOTENSIN, NUCLEOTIDES IN PREGNANCY
批准号:
3354093
负责人:
Kirk P Conrad
金额:
$5.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-01 至 1990-03-31
关键词:
angiotensin II cardiovascular function cyclic AMP cyclic GMP cyclic nucleoside monophosphate eclampsia environmental adaptation fatty acid biosynthesis gestational age hormone regulation /control mechanism image processing kidney circulation kidney function laboratory rat pregnancy pregnancy circulation pregnancy disorder prenatal stress prostaglandins radioimmunoassay renin angiotensin system tissue /cell culture vasoconstriction
中文摘要
其长期目标是阐明调控机制
孕妇的肾脏和心血管对怀孕的适应。这样的知识
将加强我们对正常妊娠的理解,而且很可能
有助于揭开先兆子痫的发病机制。这些研究
在这里提出的应该产生新的和重要的信息,主要是因为
我们实验方法的两面性。第一,网络的利用率
我们开发的人类妊娠动物模型,长期
仪器化,清醒的怀孕大鼠,不仅提供可靠的
观察孕妇对怀孕的适应,但也使
应用药物抑制剂研究血管紧张素转换酶潜在机制
荷尔蒙系统。其次,私家侦探最近获得的技术将
促进激素生物合成和受体变化的研究,
以及细胞生物学,这可能介导母体适应
怀孕了。其具体目的是:(1)检验怀孕的假设
承受“压力”的大鼠,例如钠耗竭(体积收缩),
血管扩张性前列腺素(PG)的募集比
钠耗竭的处女动物,以抵消血管收缩药
刺激物。也就是说,据推测,在限制饮食钠的情况下:
(A)抑制PG合成将导致更急剧的下降
妊娠大鼠的肾脏血流动力学比处女大鼠的肾血流动力学,(B)减弱
观察肾脏和全身对外源性血管紧张剂的升压反应
在怀孕期间会发展成PG依赖,以及(C)体外生物合成
在分离的肾小球和主动脉节段中PG的比例将更大
怀孕,而不是处女动物。(2)检验一个重大事件的假设
观察到PGE2和PGF2Alpha尿液排泄增加的来源
在妊娠期间是肾髓质/乳头。(3)确定是否或
而不是2,3-二酮或6-酮-前列腺素F1α的尿液排泄,这反映了系统性
在大鼠怀孕期间,前列环素的合成被增强。(4)测试
肾小球血管紧张素II受体密度的假说
大鼠妊娠期间肠系膜动脉减少。(5)测试
性激素(S)减弱肾脏收缩能力的假说
系膜细胞在培养中。(6)确定环状AMP和
环状GMP,一种与许多
血管扩张激素,有不同的药理作用。
在新鲜分离的肾脏和血管中作为受体偶联手段
妊娠大鼠和处女大鼠的组织。总而言之,这项提案涉及
前列腺素、血管紧张素II和环磷酰胺的潜在作用
核苷酸在母体肾脏和心血管对妊娠的适应中。
英文摘要
The long-term objective is to elucidate the mechanisms which regulate
maternal renal and cardiovascular adaptation to pregnancy. Such knowledge
will strengthen our understanding of normal gestation, and most likely
contribute to unravelling the pathogenesis of preeclampsia. The studies
proposed herein should yield new and important information, largely because
of the dual nature of our experimental approach. First, utilization of an
animal model of human gestation developed by us, the chronically
instrumented, conscious pregnant rat, provides not only reliable
observations of maternal adaptation to pregnancy, but also enables
investigation of potential mechanisms by using pharmacologic inhibitors of
hormonal systems. Second, techniques recently acquired by the P.I. will
facilitate research of alterations of hormone biosynthesis and receptors,
and of cellular biology, which may mediate maternal adaptation to
pregnancy. The specific aims are: (1) To test the hypothesis that gravid
rats subjected to "stress", e.g., sodium depletion (volume contraction),
recruit vasodilatory prostaglandins (PGs) to a greater degree than do
sodium-depleted virgin animals, in order to offset vasoconstrictor
stimuli. That is, it is postulated that with dietary sodium restriction:
(a) inhibition of PG synthesis will produce a more precipitous decline of
renal hemodynamics in pregnant than in virgin rats, (b) the attenuated
renal and systemic pressor response to exogenous vasoconstrictors observed
during pregnancy will develop PG-dependency, and (c) in vitro biosynthesis
of PGs will be greater in glomeruli and aortic segments isolated from
gravid, than virgin animals. (2) To test the hypothesis that a major
source of enhanced urinary excretion of the PGE2 and PGF2Alpha observed
during gestation is the renal medulla/papilla. (3) To ascertain whether or
not urinary excretion of 2,3 dinor6keto-PGF1Alpha, which reflects systemic
synthesis of prostacyclin, is enhanced during rat pregnancy. (4) To test
the hypothesis that angiotensin II receptor density of isolated glomeruli
and mesenteric artery is decreased during rat gestation. (5) To test the
hypothesis that sex steroid(s) attenuate the contractile capacity of renal
mesangial cells in culture. (6) To determine whether or not cyclic AMP and
cyclic GMP, compounds implicated in mediating the action of many
vasodilatory hormones, are differentially stimulated by pharmacologic as
well as receptor-coupled means in freshly isolated renal and vascular
tissues from gravid and virgin rats. In summary, this proposal addresses
the potential role of prostaglandins, angiotensin II, and cyclic
nucleotides in maternal renal and cardiovascular adaptation to pregnancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:8337222
-
项目类别:
-
资助金额:$121.26万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:8509741
-
项目类别:
-
资助金额:$116.83万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:8730697
-
项目类别:
-
资助金额:$122.26万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:8151717
-
项目类别:
-
资助金额:$125.48万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:9058150
-
项目类别:
-
资助金额:$125.61万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Mechanisms of Renal Vasodilation by Relaxin
-
批准号:7738676
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2009
-
负责人:Kirk P Conrad
-
依托单位:
Mechanisms of Renal Vasodilation by Relaxin
-
批准号:7895648
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2009
-
负责人:Kirk P Conrad
-
依托单位:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
-
批准号:6703795
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
-
批准号:7388841
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
-
批准号:7252878
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6410480
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
-
批准号:6527772
-
项目类别:
-
资助金额:$22.52万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
-
批准号:7224148
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
-
批准号:7588760
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
-
批准号:6637316
-
项目类别:
-
资助金额:$22.76万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
-
批准号:6364808
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6395947
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2000
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6108695
-
项目类别:
-
资助金额:$18.87万
-
财政年份:1999
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6296785
-
项目类别:
-
资助金额:$18.87万
-
财政年份:1999
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6272274
-
项目类别:
-
资助金额:$18.15万
-
财政年份:1998
-
负责人:Kirk P Conrad
-
依托单位:
海外基金